Arjun Luthra, Commercial Director, BioInteractions, discusses how an enhanced multi-action biocompatible coating is boosting biocompatibility and antimicrobial protection on medical devices for extensive periods of time.
The case for revolutionary technologies and solutions that greatly enhance the standards of our health services plays a significant role in our quality of living. This has never been more important than now. Innovations that protect and enhance the standard routines used by healthcare services are in constant demand and are especially critical considering the Covid-19 pandemic. As the pandemic has persisted, our healthcare services and innovative technologies battle to keep up with the viral evolutions as well as mitigate impact to core areas of healthcare services. This highlights the importance and the necessity for preventative technologies to be used at global scale to effectively prevent infections, reduce antibiotic resistance, and enhance healthcare infrastructure.
The prevention measures and standards must focus on efficacy against a broad spectrum of pathogens equal to medical device requirements, durable protection to minimise costs of implementation, and safe variations which are biocompatible to allow for large-scale application.
The pathogen and surface interface
Materials play a critical role in improving the performance of the technology and can improve the implementation and application into a range of environments and industries. The antimicrobial efficacy of materials involves critical interactions between the pathogen and surface interface. The successes of applications depend on a variety of biological events occurring at this interface and these events intensify the complications of procedures. This must be all addressed during innovation and development. The challenge of infection prevention will help us move toward long-term prevention mechanisms and enhanced medical devices, as well as industrial and consumer products. The biological events that occur at the pathogen–surface interface is critical to improving the prevention technology against pathogens. Biological responses are complex processes which are governed by a variety of factors. These factors range from surface properties to protein interactions which includes the chemistry, topography, wettability, and the composition of a surface and the biological entities present at the interface.
Infection and pathogens on surfaces have long been studied as it is a significant challenge which has impeded improvement of long-term medical devices and a range of industrial applications. A variety of techniques including silver, copper, chlorhexidine, and other leaching chemistries used on medical devices have failed to prove significant effectivity highlighting the need for an innovative solution. Randomised studies have shown that silver surface treatments have failed to reduce infection rates; they have also demonstrated that using silver-impregnated collagen cuffs can impede catheter fixation and cause the catheter to dislodge, highlighting the limits and toxic impacts of similar leaching chemistries to silver technology on eukaryotic cells.
Furthermore, it has been recommended that any catheter which has caused bacteremia should be removed immediately and only replaced once results of blood cultures have normalised. This highlights the difficulty previous technologies experience when combating infections safely on a surface over long periods of time. These approaches have had limited success and require the consistent use of antibiotics, leading to resistance and further complications.
Multi-action materials
The biological events that occur on a surface are a complex result of interactions between the surface and the proteins and cells which are present at the pathogen-surface interface. These complex challenges require a multi-action material which considers all these varying factors in one straightforward technology. Multi-action materials provide a high-performance surface which are the most effective at preventing pathogen growth, as well as the longest durability, all while improving patient safety in one easy solution.
BioInteractions Ltd has utilised their multi-action materials to develop TridAnt®, the most effective and advanced antimicrobial technology for medical devices. The technology enhances the protection against a broad spectrum of pathogens which includes gram-positive and gram-negative bacteria and yeast. TridAnt® is the only medical device coating that kills 99.999% (5 log reduction) of bacteria and yeast for up to 100 days. We use advanced multi-action materials which are biocompatible and non-leaching to ensure a consistent level of efficacy on medical devices for extensive periods of time inside a patient.
TridAnt® biocompatible, antimicrobial technology
This technology is the only medical device coating that offers the following:
- Kills 99.999% of bacteria (gram positive and gram-negative) as well as yeast.
- Consistently protects medical devices for 100 days.
- Contact-Kill technology provides a highly effective mechanism to kills broad spectrum of pathogens as they interact with the device surface
- Multi-Action material uses active and passive components to prevent deposition, protect against adhesion and kill pathogens on contact.
- Biocompatible and non-leaching coating assists in patient safety while targeting microbes.
TridAnt® technology has been derived specifically to enhance the state of the art in antimicrobial technology on medical devices. The technology uses innovative features developed from over 30 years in the medical device industry to provide revolutionary benefits to the healthcare professional as well as the patient. The technology is the first of its kind to provide market-leading efficacy and the longest duration of an antimicrobial coating on a device. This is achieved by using multi-action materials to ensure the highest efficacy seen on a medical device to date. The non-leaching mechanisms ensure that antimicrobial efficacy stays on the surface and doesn’t flow through the blood. This also ensure that the amount of active component remains constant throughout the duration of the device to ensure a complete and consistent effect while implanted in a patient. The combination of highest efficacy against a broad spectrum of pathogens for the longest duration seen on a medical device provides a platform for new procedures and products to be innovated. These benefits allow for devices to remain in the patient for longer, whilst also aiding in reducing the amount of antibiotics they are required to consume.
Infection protection infrastructure
TridAnt® has been further optimised to provide the World’s most advanced Infection Prevention Infrastructure — the first line of defence and a long-term solution to protecting surfaces, preventing transmission, and controlling pathogens. The infrastructure provides enhanced protection against a broad spectrum of bacteria, viruses, and fungi on surfaces ranging from stainless steel to skin. The infrastructure comprises products that use TridAnt® technology to enhance protection and provide further long-term benefits to the healthcare and wider industrial environment.
The use of TridAnt® as a daily tool provides a viable method to improve hygiene and healthcare standards, while reducing maintenance costs and reliance on single-use items. The various products reduce the level of consumption of harsh chemicals and provides enhanced hygiene infrastructure which prevents future pathogens. The use of TridAnt® items actively disinfects surfaces on contact, therefore actively maintaining a healthy and hygienic environment. This helps us to move into a better normal where we maintain health and hygiene conveniently as well as reducing the costs of maintain the environment.
This complete infrastructure can be applied safely into schools, restaurants, hotels and hospitals to allow a swift recovery to our normal routines. TridAnt® technology uses hygiene of the future to bring back the good phoelings (“feelings”) of the past.
